News | May 11, 2026
Bajaj Healthcare FY26 revenue rises 12.6% to Rs 6,110 million
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases
The ultrasound-based AI imaging platform is designed to support rapid fracture detection and soft tissue injury assessment in emergency care settings
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector
In collaboration with the Soham Foundation, the initiative focused on perimenopause, menopause, and hormone replacement therapy awareness at BESCOM’s Bengaluru headquarters.
Offers a non-surgical treatment option for tricuspid regurgitation, a commonly underdiagnosed heart valve disorder linked to heart failure
The public health summit in Addis Ababa will bring together policymakers, scientists, healthcare leaders, and global partners
The clinical study in France evaluated the safety and feasibility of Robocath’s robotic-assisted coronary intervention platform across complex cardiac cases.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
